Zuclopenthixol (Compound)

Synonyms:Zuclopenthixol, 53772-83-1, Clopixol, Cisordinol, CLOPENTHIXOL, Zuclopentixol [Spanish], Zuclopenthixolum [Latin], Zuclopentixol, Zuclopenthixolum, cis-Clopenthixol, Zuclopenthixol hydrochloride, 2-[4-[(3Z)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanol, Clopenthixol cis(z)-form, Sordinol, 47ISU063SG, CHEBI:51364, (Z)-Clopenthixol, (Z)-4-(3-(2-Chlorothioxanthen-9-ylidene)propyl)-1-piperazineethanol, Zuclopenthixol (INN), Clopixol (TN), ZUCLOPENTHIXOL [INN], Clopenthixolum, 982-24-1, Acuphase, Clopentixol cis-(Z)-, 4-(3-(2-Chlorothioxanthen-9-ylidene)propyl)-1-piperazineethanol, MLS002154089, 4-(3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl)-1-piperazineethanol, 2-(4-{3-[(9Z)-2-CHLORO-9H-THIOXANTHEN-9-YLIDENE]PROPYL}PIPERAZIN-1-YL)ETHAN-1-OL, NSC329015, SMR001233397, EINECS 258-758-5, Zuclopenthixol [INN:BAN], UNII-47ISU063SG, cis(Z)-cloflupentixol, Clopenthixol (USAN), Prestwick2_000998, Prestwick3_000998, BSPBio_001095, CHEMBL53904, SCHEMBL149463, ZUCLOPENTHIXOL [MART.], BPBio1_001205, GTPL7559, ZUCLOPENTHIXOL [WHO-DD], 2-(4-(3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl)piperazin-1-yl)ethanol, DTXSID3048233, BDBM79209, CHEBI:59115, cid_25102584, HY-A0163, NSC 64087, PDSP1_001122, PDSP2_001106, AKOS015856353, CLOPENTHIXOL CIS(Z)-FORM [MI], DB01624, DB13841, NCGC00179306-01, NCGC00179306-04, AC-32939, AS-82959, AB00514719, CS-0017495, D02613, D03556, EN300-21702641, Q228143, BRD-K00198051-003-01-9, BRD-K28761384-003-03-6, 4-[3-[(9Z)-2-Chloro-9H-thioxanthene-9-ylidene]propyl]-1-piperazineethanol, 1-Piperazineethanol, 4-[(3Z)-3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]-, 2-[4-[(3Z)-3-(2-chloranylthioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanol;hydrochloride, 2-[4-[(3Z)-3-(2-chloro-9-thioxanthenylidene)propyl]-1-piperazinyl]ethanol;hydrochloride, 2-[4-[(3Z)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanol;hydrochloride, 2-[4-[(3Z)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazino]ethanol;hydrochloride, 2-{4-[3-(2-chloro-10H-dibenzo[b,e]thiopyran-10-ylidene)propyl]piperazin-1-yl}ethanol, 2-{4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]piperazin-1-yl}ethan-1-ol, 2-{4-[(3Z)-3-(2-chloro-10H-dibenzo[b,e]thiopyran-10-ylidene)propyl]piperazin-1-yl}ethanol

Pubchem:PUBCHEM:5311507

Id:cd64d69e-4505-5b0f-8fc3-6e4a8454cfa7

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Zuclopenthixol's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Zuclopenthixol.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Zuclopenthixol.

Results found

Linked to

	Label	Description
	BRD-K28761384-300-01-0 Substance (Entity type)	A Substance
	BRD-K00198051-003-01-9 Substance (Entity type)	A Substance
	DCSTRUCT ID 04397 Collection (Entity type)	DrugPage Collection: (DrugCentralID:04397; PubChem_CID:5311507, FILE=drugcentral_drug_04397.json)
	DCSTRUCT ID 02877 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02877; PubChem_CID:5311507, FILE=drugcentral_drug_02877.json)
	zuclopenthixol (1e7de74e-2ef3-404a-8a36-3a26980d5e00) Collection (Entity type)	Metadatata for zuclopenthixol
	Zuclopenthixol indication Psychotic Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Zuclopenthixol indication Schizophrenia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG